Results 151 to 160 of about 1,065,405 (318)
Costs of neoadjuvant therapy. ABSTRACT Purpose Total neoadjuvant therapy (TNT) has become the standard of care in locally advanced rectal cancer, but its economic impact is unclear. This study compares the cost of TNT with conventional neoadjuvant therapy (CNT), consisting of either short‐course radiotherapy or long‐course chemoradiotherapy, within a ...
Ishraq Murshed+6 more
wiley +1 more source
As circulating tumor DNA has emerged as a promising minimal residual disease biomarker, we evaluated circulating tumor DNA detection using a sensitive, targeted 14‐gene panel, the Sysmex Plasma‐Safe‐SeqS colorectal cancer assay, in resectable colorectal cancer cases.
Yuichi Hisamatsu+13 more
wiley +1 more source
Carcinoembryonic antigen radioimmunodetection
P.W. Dykes, Arthur R. Bradwell
openaire +3 more sources
Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract [PDF]
Markku Seppälä+2 more
openalex +1 more source
ABSTRACT Objective Calcitonin (CT) represents the most important biochemical marker of medullary thyroid cancer (MTC), but has certain limits. Procalcitonin (ProCT) has been recognized as an alternative or additional marker for MTC. The aim of the study is to evaluate prospectively the role of ProCT combined with CT in the identification of MTC ...
Cristina Clausi+13 more
wiley +1 more source
An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary. [PDF]
James I. Heald, C. H. Buckley, H. Fox
openalex +1 more source
ABSTRACT Background The prognosis of biliary tract cancer (BTC) is poor, and recurrence rates remain high even after curative resection. This study aimed to compare the efficacy and safety of capecitabine and 5‐fluorouracil/leucovorin (FL) as adjuvant treatments following curative resection in patients with BTC.
Tae Seung Lee+13 more
wiley +1 more source
Carcinoembryonic antigen as a predictor of treatment outcomes in cancer patients receiving immune checkpoint inhibitors. [PDF]
Ma W+6 more
europepmc +1 more source